G. Turrisi

Lipid and Protein Oxidation in Newborn Infants after Lutein Administration

G. Buonocore, M. Longini, S. Perrone, 2014, Oxidative medicine and cellular longevity.

New pharmacological approaches in infants with hypoxic-ischemic encephalopathy.

G. Buonocore, B. Kramer, W. Balduini, 2012, Current pharmaceutical design.

New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy.

G. Buonocore, B. Kramer, W. Balduini, 2012, Current pharmaceutical design.

AO-26. Predictive power of oxidative stress markers for the early identification of newborns at high risk for free radicals related diseases

G. Buonocore, M. Longini, L. Iantorno, 2010 .

Antioxidant therapy and neuroprotection in the newborn

G. Buonocore, S. Perrone, G. Turrisi, 2008 .

LONG TERM NEURODEVELOPMENTAL OUTCOME IN A COHORT OF PRETERM INFANTS BORN AT GESTATIONAL AGE <32 WEEKS

M. G. Gatti, G. Buonocore, S. Perrone, 2013 .

Inflammation-induced immune suppression of the fetus: a potential link between chorioamnionitis and postnatal early onset sepsis

Reint K Jellema, G. Buonocore, B. Kramer, 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Effects of Lutein on Oxidative Stress in the Term Newborn: A Pilot Study

G. Buonocore, M. Longini, C. Bellieni, 2009, Neonatology.

LONG TERM NEURODEVELOPMENTAL OUTCOME IN A COHORT OF PRETERM INFANTS BORN AT GESTATIONAL AGE <32 WEEKS

M. G. Gatti, G. Buonocore, S. Perrone, 2013 .